Renovacor (Renovacor) Shares Buyback Ratio % : 2.82 (As of Jun. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Renovacor Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Renovacor's current shares buyback ratio was 2.82%.

Renovacor Shares Buyback Ratio % Historical Data

The historical data trend for Renovacor's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renovacor Shares Buyback Ratio % Chart

Renovacor Annual Data

Trend

Dec20

Dec21

Shares Buyback Ratio %

Renovacor Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Shares Buyback Ratio %	Get a 7-Day Free Trial				-2.98	2.90	-	-0.07	-0.01

Renovacor Shares Buyback Ratio % Calculation

Renovacor's Shares Buyback Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2020 )	-	Shares Outstanding (EOP) (A: Dec. 2021 ))	/	Shares Outstanding (EOP) (A: Dec. 2020 )
	=	(16.756	-	16.756)	/	16.756
	=	0.00%

Renovacor's Shares Buyback Ratio for the quarter that ended in Sep. 2022 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2022 )	-	Shares Outstanding (EOP) (A: Sep. 2022 ))	/	Shares Outstanding (EOP) (A: Jun. 2022 )
	=	(16.7677	-	16.7694)	/	16.7677
	=	-0.01%

Renovacor Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Renovacor's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Renovacor (Renovacor) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovacor Inc (AMEX:RCOR) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 8142, Greenwich, CT, USA, 06836

Website

https://www.renovacor.com

Renovacor Inc is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Its therapeutic focus is on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.

Executives

Joseph S Carroll	officer: Chief Accounting Officer	C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Gregory F Covino	director	C/O RICHARD W DAVIES HUBBELL INC, 684 DERBY MILFORD RD, ORANGE CT 06477
Joan Lau	director	C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Benz Edward J. Jr	director	C/O DECIPHERA PHARMACEUTICALS, INC., 200 SMITH STREET, WALTHAM MA 02451
Needham Thomas E. Jr.	director	MERRIMACK PHARMACEUTICALS, INC., ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE MA 02139
Frederick W Driscoll	officer: Chief Financial Officer
Jonas Grossman	director	17 STREET, SUITE 1600, NEW YORK NY 10004
Gbolahan Amusa	director	17 STATE STREET 21 FLOOR, NEW YORK NY 10004
Magdalene Cook	director, officer: Chief Executive Officer	C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Matthew Killeen	officer: Chief Scientific Officer	C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Rtw Investments, Lp	10 percent owner	40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014
Rtw Master Fund, Ltd.	10 percent owner	C/O WALKERS CORPORATE LIMITED, 190 ELGIN AVENUE, GEORGE TOWN, GRAND CAYMAN E9 KY1-9008
Roderick Wong	10 percent owner	C/O RTW INVESTMENTS, LP, 40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014
Marc Semigran	officer: Chief Medical Officer	C/O MYOKARDIA, INC., 333 ALLERTON AVE, SOUTH SAN FRANCISCO CA 94080
Wendy F Dicicco	officer: Interim CFO